Drug Information

Drug General Information
Drug ID
D0D0FX
Former ID
DNC013506
Drug Name
1-(1,3,4-oxadiazol-2-yl)octadec-9-en-1-one
Drug Type
Small molecular drug
Indication Discovery agent Investigative [529594]
Structure
Download
2D MOL

3D MOL
Formula
C20H34N2O2
Canonical SMILES
CCCCCCCCC=CCCCCCCCC(=O)C1=NN=CO1
InChI
1S/C20H34N2O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-19(23)20-22-21-18-24-20/h9-10,18H,2-8,11-17H2,1H3/b10-9-
InChIKey
JPZIIIRVMJASPM-KTKRTIGZSA-N
PubChem Compound ID
44389962
Target and Pathway
Target(s) Fatty-acid amide hydrolase Target Info Inhibitor [529594]
BioCyc Pathway Anandamide degradation
KEGG Pathway Retrograde endocannabinoid signaling
PANTHER Pathway Anandamide degradation
References
Ref 529594J Med Chem. 2008 Aug 14;51(15):4392-403. Epub 2008 Jul 16.Optimization of the central heterocycle of alpha-ketoheterocycle inhibitors of fatty acid amide hydrolase.
Ref 529594J Med Chem. 2008 Aug 14;51(15):4392-403. Epub 2008 Jul 16.Optimization of the central heterocycle of alpha-ketoheterocycle inhibitors of fatty acid amide hydrolase.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.